DCM
MRNA icon

Dimension Capital Management’s Moderna MRNA Stock Holding History

Dimension Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,300
Closed -$401K – 105
2023
Q2 		$401K Buy
3,300
+1,649
+100% +$220K 0.09% 69
2023
Q1 		$254K Hold
1,651
– – 0.06% 78
2022
Q4 		$297K Buy
+1,651
New +$270K 0.07% 79
2022
Q3 		– Sell
-1,651
Closed -$236K – 109
2022
Q2 		$236K Sell
1,651
-1
-0.1% -$143 0.05% 85
2022
Q1 		$284K Sell
1,652
-850
-34% -$143K 0.05% 94
2021
Q4 		$636K Sell
2,502
-1,142
-31% -$334K 0.12% 61
2021
Q3 		$1.4M Buy
3,644
+1,448
+66% +$534K 0.29% 42
2021
Q2 		$516K Sell
2,196
-1,604
-42% -$287K 0.11% 67
2021
Q1 		$497K Buy
+3,800
New +$551K 0.12% 72

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Dimension Capital Management's MRNA Position: Q3 2023 in Review

Dimension Capital Management sold out of Moderna (MRNA) in Q3 2023, closing a stake of 3,300 shares — an estimated $401K sold.

Dimension Capital Management first reported a position in MRNA in Q1 2021 and held it in 9 quarters. The position peaked at $1.4M in Q3 2021. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Dimension Capital Management reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Dimension Capital Management sold 3,300 Moderna shares in Q3 2023, an estimated $401K.
  • Dimension Capital Management first reported a position in Moderna in Q1 2021 and held it in 9 quarters.
  • Dimension Capital Management's Moderna position peaked at $1.4M in Q3 2021.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Dimension Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.